Network Version
Product Name: | WEHI-539 hydrochloride | |
---|---|---|
CAS No.: | 2070018-33-4 | |
Cat. No.: | HY-15607A | |
MWt: | 620.18 | |
Formula: | C31H30ClN5O3S2 | |
Purity : | >98% | |
Solubility: | H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 50 mg/mL (80.62 mM; Need ultrasonic) | |
Mechanisms: | Target: Cancer | |
Biological Activity: | ||
WEHI-539 hydrochloride is a selective inhibitor of Bcl-XL with an IC50 of 1.1 nM. IC50 & Target:IC50: 1.1 nM (Bcl-XL)[1] In Vitro: WEHI-539 hydrochloride is a selective inhibitor of Bcl-XL. WEHI-539 augments NSC 241240 induced caspase 3/7 activity, PARP cleavage and annexin V labelling. WEHI-539 as a single agent causes noticeable PARP cleavage in Ovcar-4 (5 μM in Ovcar-4.) and Ovsaho (1 μM in Ovsaho) cells[2]. |
1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA
Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected] Web:www.medchemexpress.com
Keywords: buy WEHI-539 hydrochloride | WEHI-539 hydrochloride Supplier | purchase WEHI-539 hydrochloride | WEHI-539 hydrochloride cost | WEHI-539 hydrochloride manufacturer | order WEHI-539 hydrochloride | WEHI-539 hydrochloride distributor | WEHI-539 hydrochloride structure buy 2070018-33-4 | 2070018-33-4 Supplier | purchase 2070018-33-4 | 2070018-33-4 cost | 2070018-33-4 manufacturer | order 2070018-33-4 | 2070018-33-4 distributor | 2070018-33-4 structure